Dr. Jingjing Yu will be contributing to the Second Nordic Conference on Personalized Medicine (June 14-16, 2023 – Turku, Finland) with a presentation entitled “Drug-Drug Interactions in the New FDA Therapy Approvals: Mechanism and Clinical Significance“.